BerandaABCL • NASDAQ
add
AbCellera Biologics Inc
$2,76
Setelah Jam Perdagangan Normal:(0,36%)-0,0100
$2,75
Tutup: 22 Nov, 20.00.00 GMT-5 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$2,72
Rentang hari
$2,71 - $2,83
Rentang tahun
$2,34 - $6,05
Kapitalisasi pasar
815,21Â jt USD
Volume Rata-Rata
2,37Â jt
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 6,51Â jt | -1,39% |
Biaya operasional | 59,20Â jt | 151,15% |
Laba bersih | -51,11Â jt | -78,63% |
Margin laba bersih | -785,42 | -81,16% |
Penghasilan per saham | -0,17 | -70,00% |
EBITDA | -56,74Â jt | -15,44% |
Tarif pajak efektif | 18,40% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 643,14Â jt | -18,16% |
Total aset | 1,39Â M | -7,89% |
Total liabilitas | 314,73Â jt | -4,46% |
Total ekuitas | 1,08 M | — |
Saham yang beredar | 295,37 jt | — |
Harga terhadap nilai buku | 0,75 | — |
Tingkat pengembalian aset | -16,69% | — |
Tingkat pengembalian modal | -20,08% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -51,11Â jt | -78,63% |
Kas dari operasi | -28,88Â jt | -27.147,17% |
Kas dari investasi | 3,70Â jt | 128,92% |
Kas dari pembiayaan | 3,14Â jt | -52,56% |
Perubahan kas bersih | -21,67Â jt | -195,86% |
Arus kas bebas | -10,48Â jt | 72,64% |
Tentang
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology firm that researches and develops human antibodies. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
CEO
Didirikan
2012
Kantor pusat
Situs
Karyawan
586
